19:34 , May 17, 2018 |  BC Innovations  |  Finance

Europe’s piece of the pie

With China’s rising infrastructure for life science innovation and the unabated growth of U.S. science, Europe has two cards to play that can help it compete globally: expertise in key core technologies and its centralized...
18:36 , Nov 30, 2017 |  BC Innovations  |  Translation in Brief

New Therapeutic Targets and Biomarkers: November 2017

New Therapeutic Targets and Biomarkers: November 2017 Select top therapeutic targets and biomarkers covered by BioCentury or added to the BCIQ database during November 2017. Therapeutic targets are defined as any protein, gene or other molecule...
21:26 , Nov 10, 2017 |  BC Week In Review  |  Company News

ADCendo licenses ADCs from University of Copenhagen

Newco ADCendo ApS (Copenhagen, Denmark) received exclusive, worldwide rights to antibody-drug conjugates (ADCs) targeting mannose receptor C type 2 (MRC2) from the University of Copenhagen and the Capital Region of Denmark. ADCendo plans to use...
23:08 , Nov 3, 2017 |  BC Extra  |  Company News

Newco ADCendo licenses tech from University of Copenhagen

Newco ADCendo ApS (Copenhagen, Denmark) received exclusive, worldwide rights to antibody-drug conjugates (ADCs) targeting mannose receptor C type 2 (MRC2) from the University of Copenhagen and the Capital Region of Denmark. ADCendo plans to use...